<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with genetic defects of the cyclic (c) <z:chebi fb="3" ids="16335">adenosine</z:chebi>-monophosphate (<z:chebi fb="47" ids="16027,28971">AMP</z:chebi>)-signaling pathway and those with <z:hpo ids='HP_0003623'>neonatal-onset</z:hpo> multisystem <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e>) develop <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-like lesions of the long bones </plain></SENT>
<SENT sid="1" pm="."><plain>The molecular basis of this similarity is unknown </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e> is caused by inappropriate caspase-1 activity, which in turn activates the inflammasome </plain></SENT>
<SENT sid="3" pm="."><plain>The present study demonstrates that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e> <z:e sem="disease" ids="C0238792" disease_type="Disease or Syndrome" abbrv="">bone lesions</z:e> are derived from the same osteoblast progenitor cells that form fibroblastoid <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in mice and humans with defects that lead to increased cAMP-dependent protein kinase A (PKA) signaling </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells showed high PKA activity, and an increase in their cAMP signaling led to PKA-specific activation of caspase-1 </plain></SENT>
<SENT sid="5" pm="."><plain>Increased PKA led to <z:mp ids='MP_0001845'>inflammation</z:mp>-independent activation of caspase-1 via over-expression of the proto-oncogene (and early osteoblast factor) Ets-1 </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, as in cells with defective PKA regulation, increased <z:chebi fb="0" ids="15551">prostaglandin E2</z:chebi> (<z:chebi fb="0" ids="15551">PGE2</z:chebi>) led to increased cAMP levels and activation of Wnt signaling, like in other states of inappropriate PKA activity </plain></SENT>
<SENT sid="7" pm="."><plain>Caspase-1 and <z:chebi fb="0" ids="15551">PGE2</z:chebi> inhibition led to a decrease in cell proliferation of both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e> and cells with abnormal PKA </plain></SENT>
<SENT sid="8" pm="."><plain>These data reveal a previously unsuspected link between abnormal cAMP signaling and defective regulation of the inflammasome and suggest that caspase-1 and <z:chebi fb="0" ids="15551">PGE2</z:chebi> inhibition may be therapeutic targets in <z:e sem="disease" ids="C0238792" disease_type="Disease or Syndrome" abbrv="">bone lesions</z:e> associated with defects of these two pathways </plain></SENT>
</text></document>